Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Astrocytoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT00978458
What this trial is testing

Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma

Who this might be right for
Brain and Central Nervous System TumorsNeurotoxicity
Eastern Cooperative Oncology Group 540
Early research (Phase 1)Study completedNCT00022360
What this trial is testing

Taurolidine in Treating Patients With Recurrent or Progressive Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Looking for participantsNCT04541082
What this trial is testing

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

Who this might be right for
Central Nervous System NeoplasmsGlioblastomaGliosarcoma, Adult+20 more
Jazz Pharmaceuticals 102
Not applicableWithdrawnNCT07553520
What this trial is testing

Dietary Cysteine and Methionine Deprivation (CMD) in Glioma Patients

Who this might be right for
Glioblastoma MultiformeRecurrent Glioma
UNC Lineberger Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01403610
What this trial is testing

Safety and Efficacy Study of TH-302 CNS Penetration in Recurrent High Grade Astrocytoma Following Bevacizumab

Who this might be right for
HIGH GRADE GLIOMA
The University of Texas Health Science Center at San Antonio 28
Testing effectiveness (Phase 2)Study completedNCT00895180
What this trial is testing

Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Adult Glioblastoma Multiforme
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 80
Early research (Phase 1)WithdrawnNCT03275558
What this trial is testing

Clinical Trial of the Use of the Nasal Spray of Patients With Recurrence of Glioblastoma

Who this might be right for
Recurrent GlioblastomaGliosarcomaAnaplastic Gliomas
Center Trials & Treatment
Testing effectiveness (Phase 2)Ended earlyNCT03430791
What this trial is testing

Trial of Combination Tumor Treating Fields (TTF; Optune), Nivolumab Plus/Minus Ipilimumab for Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
Baptist Health South Florida 5
Testing effectiveness (Phase 2)Study completedNCT00941460
What this trial is testing

Comparison of Two Dosing Regimens of Temozolomide in Patients With Progressive or Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Prof. Dr. Wolfgang Wick 105
Testing effectiveness (Phase 2)Study completedNCT00104091
What this trial is testing

Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors

Who this might be right for
Glioblastoma Multiforme
Teva Branded Pharmaceutical Products R&D, Inc. 56
Testing effectiveness (Phase 2)Study completedNCT01753713
What this trial is testing

Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more
Manmeet Ahluwalia, MD 33
Testing effectiveness (Phase 2)Study completedNCT00014573
What this trial is testing

Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer

Who this might be right for
Brain and Central Nervous System Tumors
Barbara Ann Karmanos Cancer Institute
Early research (Phase 1)Study completedNCT01250470
What this trial is testing

Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+5 more
Roswell Park Cancer Institute 9
Early research (Phase 1)Ended earlyNCT00238173
What this trial is testing

Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors

Who this might be right for
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ+1 more
OHSU Knight Cancer Institute 2
Testing effectiveness (Phase 2)Study completedNCT01466686
What this trial is testing

Low Dose Radiation Therapy for Glioblastoma Multiforme

Who this might be right for
High Grade Glioma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 31
Testing effectiveness (Phase 2)Study completedNCT00003241
What this trial is testing

Phenylacetate in Treating Children With Recurrent or Progressive Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Texas Children's Cancer Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07138001
What this trial is testing

Phase 2 Clinical Trial of KH617

Who this might be right for
Recurrent Glioblastoma
Sichuan Honghe Biotechnology Co., Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT01582269
What this trial is testing

A Study in Recurrent Glioblastoma (GB)

Who this might be right for
Glioblastoma
Eli Lilly and Company 158
Testing effectiveness (Phase 2)Ended earlyNCT01575275
What this trial is testing

Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more
Michael Vogelbaum, MD, PhD 8
Testing effectiveness (Phase 2)Ended earlyNCT04006119
What this trial is testing

Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive Glioblastoma

Who this might be right for
Glioblastoma
Alaunos Therapeutics 40
Next Page